What are the findings regarding adverse events among Covaxin study participants

- Adverse events reported among Covaxin study participants were generally mild to moderate in nature. - Common adverse events included pain at the injection site, headache, fatigue, fever, and nausea. - These events were reported to be transient and resolved within a few days. - Serious adverse events were rare, and no significant safety concerns were identified during the study. - Overall, Covaxin was found to have a favorable safety profile in clinical trials. - Continuous monitoring and evaluation of adverse events are ongoing to ensure the safety and efficacy of the vaccine.